LBK Lifebank Corp.

Lifebank Corp. ("Lifebank" or the "Company") (TSX VENTURE:LBK) announced today
the appointment of Jeff Charpentier as Chief Financial Officer. Mr. Charpentier
assumes his new role effective November 5, 2010.


Mr. Charpentier is an experienced financial executive who, over the past 15
years, has led the financial and fiscal management aspects of several Canadian
publicly traded companies. 


"Jeff is a great addition to our executive team and brings strong financial
acumen to his new role," says Lifebank President and CEO Ernest Stacey. "He has
a proven track record of financial expertise, and will play a key role in the
Company's financial and strategic initiatives." 


Mr. Charpentier graduated from the University of British Columbia, Bachelor of
Commerce, and is a Chartered Accountant (CA) of the Institute of Chartered
Accountants of British Columbia.


Mr. Charpentier replaces Mr. Owen Granger. Effective today, Mr. Granger resigns
as a Director and Chief Financial Officer and Secretary Treasurer of Lifebank. 


About Lifebank.

Started in 1996, Lifebank is a leading national company in the biomedical field.
Based at the British Columbia Institute of Technology campus in Burnaby,
Lifebank provides processing and cryogenic (ultra low temperature) storage of
umbilical cord blood stem cells for families in Canada and world-wide. A full
description of the advantages and benefits of storing the stem cells from an
infant's umbilical cord can be found on the Company's website at
www.lifebank.com.


On January 21, 2004, Lifebank received official accreditation from the
international organization AABB and was the first accredited cord blood stem
cell bank in Canada. In February 2010, celebrating another milestone in Cellular
Therapy and Transplant Medicine, Lifebank has achieved the globally recognized
FACT accreditation.

Lifebank Corp. (TSXV:LBK)
Historical Stock Chart
From May 2024 to Jun 2024

Lifebank Corp. (TSXV:LBK)
Historical Stock Chart
From Jun 2023 to Jun 2024